commercial-phases_LBB_phase-0_foundation_color_800x800
Phase 0

Foundation

We help you build the commercial strategy your innovation needs to compete. Before there’s clinical data or a cleared device, there’s a market case that investors, partners, and early stakeholders need to believe.

Phase overview

Foundation is the starting point of commercialization. In this phase, you establish the strategic and investor infrastructure your company needs, typically while it is pre-clinical or in early development. The focus is on protecting IP, validating the business model, and building the case that supports fundraising and partnerships. The quality of the strategic foundation built here shapes every commercial decision that follows.


What happens in this phase

Each phase draws on a different combination of our disciplines and sub-disciplines. These are the ones that establish the strategic and brand infrastructure your innovation will build on.

Market Research

Primary research and competitive analysis that size the opportunity and ground decisions in evidence.

Market & Investor Strategy

Market assessment, forecasting, and a fundraising narrative that build investor confidence.

Business Model Strategy

Revenue model, channel priorities, cost structure, and path to profitability.

Product Strategy

Commercial input into product requirements before major design decisions are locked.

Reimbursement

An early assessment of the coding, coverage, and payment landscape investors will ask about.

Brand Strategy

Brand architecture and positioning that build early credibility with key stakeholders.

_BK25156_1 Color (800 x 800)

What you walk away with

You leave Foundation with a sized market opportunity, a defined business model and path to profitability, and an investor narrative built to support your raise. Your product requirements reflect what the market will buy, you have an early view of the reimbursement landscape, and your brand strategy and positioning are in place to build credibility with early stakeholders.

Why this phase matters

Investors, talent, and clinical partners commit to companies before they can evaluate a device, so they judge the strength of the market case and the credibility of the team. A deliberate foundation makes later raises, partnerships, and commercial decisions easier. A reactive one forces rework under pressure, usually when it matters most.

commercial-phases_LBB_phase-1_clinical-evidence_color_800x800
NEXT PHASE

Clinical Evidence

With the market case and business model in place, the program moves into first human data and the evidence strategy that builds stakeholder conviction.

Content Card - Just Mighty - Launch - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But is your strategy up to the task? We help you turn Just Might into Just Mighty.